Drugs / RQ-00000010
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02838797 | Jun 2016 → Aug 2019 | Parkinson disease, constipation disorder, gastroparesis | Virginia Commonwealth University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RQ-00000010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02838797 ↗ |
| Action | Activate | “orally administered serotonin 4 receptor partial agonist” NCT02838797 ↗ |
| Route | Oral | “orally administered” NCT02838797 ↗ |